-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

114. Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological: Poster III

Symposia: Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Min Dong1,2*, Alina Sadaf, MBBS3, Alexander A. Vinks, PharmD, PhD, FCP1,2*, Russell E. Ware2,3 and Charles T. Quinn, MD2,3

1Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
3Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Landon C. Power1*, Amy E. Mirro, MEng2*, Michael M. Binkley, PhD3*, Kristin P. Guilliams, MD, MSCI2,3*, Josiah B. Lewis, PhD3*, Jade Beshears, BA3*, Andria L. Ford, MD, MSCI3,4*, Joshua S. Shimony, MD, PhD4*, Hongyu An, DSc4*, Jin-Moo Lee, MD, PhD3,4,5* and Melanie E. Fields, MD6

1Department of Pediatrics, Washington University School of Medicine, Hastings, NE
2Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO
3Department of Neurology, Washington University School of Medicine, Saint Louis, MO
4Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO
5Department of Biomedical Engineering, Washington University School of Medicine, Saint Louis, MO
6Division of Pediatric Hematology/Oncology, Washington University in St. Louis, Saint Louis, MO

Akshay Sharma, MBBS1, John P Manis, MD2, David G. Justus, MD3*, David A. Williams, MD3*, Sergey Efuni, MD, PhD4*, Ji Hyun Lee, MD, MPH4*, Erin Conlin, MS4*, Shawn Rose, MD, PhD4, Jeffrey Humphrey, MD4, Kirk Bertelsen, PhD4*, Nicole Henry, BSN, RN4*, June Li, PhD4*, Donald Pardy, MS4*, David Santos, BS4*, Christian Zdybowicz, MBA4*, Alexis Leonard, MD5* and John Tisdale, MD5

1St. Jude Children's Research Hospital, Memphis, TN
2Department of Laboratory Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA
3Boston Children's Hospital, Boston, MA
4Magenta Therapeutics, Cambridge, MA
5Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Slimane Allali, MD, PhD1,2,3*, Juliette Elie, MD2,3*, Mariane de Montalembert, MD, PhD1,2, Melissa Taylor, MD, PhD1,2*, Joséphine Brice, MD, PhD2*, Stéphanie Chhun, PharmD, PhD4*, Rachel Rignault-Bricard, BSc1,3*, Claire Heilbronner, MD5*, Thiago Trovati Maciel, PhD1,3* and Olivier Hermine, MD, PhD1,3*

1Laboratory of Excellence GR-Ex, Paris, France
2Department of General Pediatrics and Pediatric Infectious Diseases, Sickle Cell Center, Necker-Enfants malades Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
3Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université Paris Cité, Imagine Institute, Inserm U1163, Paris, France
4INEM U1151 "Immunorégulation et Immunopathologie", Laboratoire d’Immunologie biologique, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
5Department of Pediatric Intensive care, Necker-Enfants malades Hospital, AP-HP, Université Paris Cité, Paris, France

Ashwin Patel, MD, MPH1*, Dorothy Kim Waller, PhD1*, Luis Leon Novelo, PhD1*, Jonathan M. Flanagan, PhD2 and Vivien A. Sheehan, MD, PhD3

1The University of Texas Health Science Center at Houston (UTHealth), School of Public Health, Houston, TX
2Department of Pediatrics - Hematology/Oncology, Baylor College of Medicine, Houston, TX
3Department of Pediatrics, Emory University School of Medicine, Atlanta, GA

Kuldeepsinh Atodaria, MBBS1, Richard S Eisenstaedt, MD1*, Christian Joseph Fidler, MD2* and Sarin Atam, MD1*

1Jefferson Health - Abington, Abington, PA
2Hematology and Medical Oncology, Jefferson Health - Abington, Abington, PA

Maria A. Lizarralde-Iragorri, PhD1*, Bindu Parachalil Gopalan, PhD1*, Brenda Merriweather, RN, MSN1*, Jennifer Brooks, RN2*, Mai Hill, RN, BSN, MHSA1*, Anna Conrey, NP1*, Ruth Pierre Charles, DSc, PA-C1*, Eveline Gwaabe, CRNP1*, Neal Jeffries, PhD3* and Arun S. Shet, MD, PhD1

1Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
3Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Bindu Parachalil Gopalan, PhD1*, Maria A. A. Lizarralde-Iragorri, PhD1*, Anna Conrey, NP1*, Mai Hill, RN, BSN, MHSA1*, Brenda Merriweather, RN, MSN1*, Jennifer Brooks, RN2*, Ruth Pierre Charles, DSc, PA-C1*, Eveline Gwaabe, CRNP1*, Rafael Villasmil, M.Sc., C.Cy.3*, Neal Jeffries, PhD4* and Arun S. Shet, MD, PhD1

1Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
3Flow Cytometry Core Facility, National Eye Institute, National Institutes of Health, Bethesda, MD
4Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Ada Chang, BSc1*, Sherri Morris, MSN, AGPCNP-BS2*, Barbara L LeVarge, MD3*, Samuel R Wilson, MD, MSCR2* and Jane Alison Little, MD4,5,6

1School of Medicine, UNC Blood Research Center, University of North Carolina, Chapel Hill, Chapel Hill, NC
2Department of Medicine, Division of Hematology, University of North Carolina, Chapel Hill, Chapel Hill, NC
33. Department of Medicine, Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina, Chapel Hill, Chapel Hill, NC
4Department of Medicine, UNC Adult Sickle Cell Program, Chapel Hill, NC
5Departments of Pediatrics and Medicine, UNC Hospitals, Chapel Hill, NC
6Department of Medicine, Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, NC

Caterina P Minniti, MD1, Henny H. Billett, MD MSc2, Daniel McMahon, MD3, Modupe Idowu, MD4, Nirmish Shah, MD5, Richard A. Drachtman, MD6, Archana Sharma, DO6*, Alexander Glaros, MD7, Maureen Okam Okam Achebe, MD, MPH8, Alecia C Nero, MD9*, Susanna Curtis, MD, PhD10 and Biree Andemariam, MD11

1Department of Hematology, Einstein College of Medicine, Chevy Chase, MD
2Division of Hematology, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
3Atrium Health Levine Cancer Institute, Charlotte, NC
4University of Texas McGovern Medical School, Houston, TX
5Division of Hematology, Duke University School of Medicine, Durham, NC
6Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
7Children's Hospital of Michigan, Department of Pediatrics, Division of Pediatric Hematology-Oncology, Central Michigan University, Detroit, MI
8Hematology Division Brigham and Women's, Boston, MA
9University of Texas Southwestern Medical Center, Dallas, TX
10Icahn School of Medicine at Mount Sinai, New York
11New England Sickle Cell Institute at the University of Connecticut, Farmington, CT

Claudia Rodriguez Rivera, MD1*, Andrew Srisuwananukorn, MD2*, Rizma Jalees Bajwa, MD1*, Victor R. Gordeuk, MD3, Joyce Rauch, PhD4*, Jerrold Levine, MD1* and Santosh L. Saraf, MD5

1University of Illinois at Chicago, Chicago
2Mount Sinai Health System, New York, NY
3Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
4McGill University Health Centre, MONTREAL, QC, CAN
5Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL

Syeda Akila Ally, BA1*, Jin Han, PharmD, PhD2*, Robert E. Molokie, MD3, James P. Lash, MD4*, Victor R. Gordeuk, MD5 and Santosh L. Saraf, MD6

1University of Illinois at Chicago, Chicago, IL
2Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL
3Department of Medicine, University of Illinois at Chicago, Jesse Brown VA Medical Center, Chicago, IL
4University of Illinois at Chicago, Chicago
5Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Carol Stream, IL
6Department of Medicine, University of Illinois at Chicago, Chicago, IL

Neha J Desai, DO1, Ana Lucia Gonzalez-Herrera, MD2*, Sindhoosha Malay, MPH, PharmD2*, Tracie Brown, FNP-C3*, Amma Owusu-Ansah, MD3* and Sanjay Ahuja, MD4

1Division of Pediatric Hematology & Oncology, University Hospitals Rainbow Babies & Children's Hospital, Cleveland Heights, OH
2Department of Pediatrics, University Hospitals Rainbow Babies & Children's Hospital, Cleveland, OH
3Division of Pediatric Hematology & Oncology, University Hospitals Rainbow Babies & Children's Hospital, Cleveland, OH
4Division of Pediatric Hematology & Oncology, Rainbow Babies and Children's Hospital, Cleveland, OH

Jayla Lynn Scott1*, Jana Christian, MD2*, Manuela Plazas Montana2*, Yvette M. Miller, MD3* and Rakhi P. Naik, MD, MHS2

1Johns Hopkins University, Baltimore, MD
2Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD
3American Red Cross, Charlotte, NC

Kayla Baker, MSBHS1*, Michael Ho1*, Chibuzo C Ilonze, MD, MPH2, Malgorzata Kasztan, PhD1 and Jeffrey D. Lebensburger, DO, MSPH3

1University of Alabama at Birmingham, Birmingham, AL
2Division of Pediatric Hematology and Oncology, Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, AL
3Division of Pediatric Hematology Oncology, University of Alabama At Birmingham, Birmingham, AL

Kok Hoe Chan, MD1, Ruhi Buddharaju, BA2*, Shandel L Chang, BS2*, John S Lane, DO2* and Modupe Idowu, MD1

1Department of Internal Medicine, Division of Hematology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX
2McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX

Reema Kashif, MD1, Mark Rodeghier, PhD2*, Shaina M Willen, MD3, Michael R. DeBaun, MD, MPH4 and Evans Machogu, MD5*

1Department of Pediatrics, Division of Hematology Oncology, University of Florida, Gainesville, FL
2Statistical Consultant, Rodeghier Consultants, Chicago, IL
3Department of Pediatrics, Division of Pulmonary Medicine, University of California - Davis, Sacramento, CA
4Department of Pediatrics, Division of Hematology & Oncology, Vanderbilt University School of Medicine, Nashville, TN
5Department of Pediatrics, Division of Pulmonology, Allergy, and Sleep Medicine, Riley Hospital for Children at Indiana University Health, Indianapolis, IN

Abisola Baruwa Etti, MBBS1*, Chia-ling Kuo, Ph.D2*, Lucas Da Cunha Godoy, M.Sc3* and Biree Andemariam, MD4

1Internal Medicine, University of Connecticut Health Center, Farmington, CT
2Connecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health Center, Farmington
3Connecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health Center, Farmington, CT
4New England Sickle Cell Institute, University of Connecticut Health, Farmington, CT

Amy Parker Ruhl, MD, MHS1*, Ruba Shalhoub, MS2*, Neal Jeffries, PhD3*, Alexis Leonard, MD4*, Emily Limerick, MD3*, Amisha Barochia, MBBS, MHS5*, Matthew M. Hsieh, MD4 and Courtney D. Fitzhugh, MD3

1Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Washington, DC
2Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
3National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
4Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
5Pulmonary Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Rowan O. Brothers, BS1*, Katherine B. Turrentine, BS1*, Mariam Akbar, BS1*, Sydney Triplett, BS1*, Tara M. Urner, BS1*, Amy Y. Tang, MD2,3*, Clark Brown, MD, PhD2,4,5 and Erin M. Buckley, PhD1,2,5*

1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA
2Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, Atlanta, GA
3Department of Pediatrics, Emory University, Atlanta, GA
4Global Blood Therapeutics, South San Francisco, CA
5Department of Pediatrics, Emory University School of Medicine, Atlanta, GA

Yang Dai1*, Kelley Hill1*, Daniel Harris1*, Tong Shen1*, Chao-Xing Yuan1* and Christoph Gasteyger2*

1Alexion, AstraZeneca Rare Disease, Boston, MA
2Alexion, AstraZeneca Rare Disease, Zurich, MA, Switzerland

Christophe Ferreira De Matos, MD1*, Pierre Cougoul, MD2*, Oana Zaharie, MD1*, Aurore Perrot, MD, PhD3*, Marc Kermorgant, PhD4*, Anne Pavy-Le Traon, MD, PhD1*, Celine Gales, PhD5*, Jean-Michel Senard, MD, PhD5*, Fabrice Bonneville, MD, PhD1* and Nathalie Nasr, MD, PhD6*

1Centre hospitalier universitaire de Toulouse, Toulouse, France
2Oncopole, Toulouse, FRA
3CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
4UMR 1297 Equipe 10 Institute of Metabolic and Cardiovascular Disease (I2MC) Toulouse France, Toulouse, France
5UMR 1297 equipe 10 Institute of Metabolic and Cardiovascular Disease (I2MC), Toulouse, France
6Department of Neurology Toulouse University Hospital, Centre hospitalier universitaire de Toulouse, Toulouse, France

Stephanie H Guarino, MD1,2, Mark D Nelms, PhD3*, David Williams, MEng4*, Amanda M. Brandow, DO, MS5, C. Patrick Carroll, MD6*, Nitya Bakshi, MBBS, MS7, Claudia M Campbell, PhD8*, Deepika S. Darbari, MD9, Martha Kenney, MD10*, Wally R Smith, MD11, Jennifer Stinson, PhD, CNP, RN12*, William Zempsky, MD13*, Wayne Huggins, PhD4*, Deborah Maiese, MPA4*, Tabitha Hendershot, BA4* and Carol Hamilton, PhD4*

1Nemours Dupont Hospital For Children, Wilmington, DE
2Center for Special Health Care Needs/Institute on Research in Equity and Community Health, ChristianaCare, Newark, DE
3RTI International, Durham, NC
4RTI International, Research Triangle Park, NC
5Medical College of Wisconsin, Milwaukee, WI
6Johns Hopkins University School of Medicine, Baltimore, MD
7Department of Pediatrics/Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA
8Department of Psychiatry and Behavioral Health, Johns Hopkins University School of Medicine, Baltimore, MD
9Comprehensive Sickle Cell Disease Program, Children's National Hospital, Washington, DC
10Duke University, Durham, NC
11Internal Medicine, Virginia Commonwealth University, Richmond, VA
12Hospital For Sick Children, Toronto, ON, CAN
13University of Connecticut School of Medicine, Connecticut Children's Medical Center, Hartford, CT

Macy L. Early, BA1, A. Kinga Malinowski, MD, MSc, FRCSC2, Marissa Solow, MD3*, Ahizechukwu Eke, MBChB, PhD4,5*, Nadine Shehata, MD, FRCPC, MSc6,7,8, Sana Saif Ur Rehman, MD9*, Kevin H.M. Kuo, MD, MSc, FRCPC10,11,12 and Lydia H. Pecker, MD13

1Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD
2Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Mt. Sinai Hospital, Toronto, ON, CAN
3University Health Network, Toronto, ON, Canada
4Division of Clinical Pharmacology, Johns Hopkins School of Medicine, Baltimore, MD
5Division of Maternal-Fetal Medicine, Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD
6Department of Medicine, Toronto, Canada
7Mount Sinai Hospital, Toronto, ON, Canada
8Canadian Blood Services, Toronto, ON, Canada
9Division of Hematology, Washington University School of Medicine, Saint Louis, MO
10Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
11Division of Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada
12Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, ON, Canada
13Division of Hematology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD

Fuad El Rassi, MD1,2, Ross M. Fasano, MD3* and Morgan L. McLemore4,5

1Department of Hematology and Medical Oncology, Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System, Atlanta, GA
2Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, GA
3Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA
4Grady Health System, Atlanta, GA
5Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

Nour Belkeziz1*, Marie-Pierre Gobin-Metteil2*, Corentin Provost1*, Suella Martino, MD PhD3*, Myriam Edjlali4*, Nicolas Mele1*, Benjamin Maïer2*, Anne Blanchet-Deverly5*, Jean-Benoit Arlet6*, Laure Joseph, MD7*, Pablo Bartolucci, MD, PhD8* and David Calvet, MD, PhD2*

1Centre Hospitalier Sainte-Anne, Paris, France
2Centre Hospitalier Sainte-Anne, Paris, FRA
3APHP Hôpital Henri Mondor, Creteil, France, Creteil, France
4CENTRE HOSPITALIER SAINTE ANNE, INSERM S 894, PARIS, FRA
5CHU de Guadeloupe, Poite à Pitre, France
6Hopital Europeen Georges Pompidou, Paris, FRA
7Biotherapy Department, French National Sickle Cell Referral Center, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, DC, France
8Université Paris-Est Créteil, INSERM, IMRB, Laboratory of excellence LABEX GRex, Créteil, France

Anoosha Habibi, MD, PhD1,2, Marion Lefebvre, MD3*, Octavia Sobcyk, MD4*, Florence Canouï-Poitrine, MD5*, Amna Jebali, MD6*, Gonzalo De Luna, MD7*, Pablo Bartolucci, MD, PhD8,9*, Frédéric Galactéros, MD, PhD10,11*, France Pirenne, MD, PhD8,12, Diane Redel13*, Emmanuelle Boutin, MD14*, Bassam Haddad, MD, PhD15,16* and Edouard Lecarpentier, MD, PhD3*

1IMRB-U955, Equipe 2 émergente: Transfusion et maladies du globule rouge, CRETEIL, France
2Sickle cell disease french referral center , Henri-Mondor university hospital, Créteil, France
3Service de Gynécologie Obstétrique,, Centre Hospitalier Intercommunal de Créteil, Créteil, France
4Centre Hospitalier Intercommunal de Créteil, CRETEIL, France
5Department of Public Health and Biostatistics, Henri Mondor Hospital, Creteil, France
6Sickle cell referral center, APHP Hôpital Henri Mondor, Creteil, France, Creteil, France
7Sickle cell referal Center, APHP Hôpital Henri Mondor, Creteil, France, Creteil, France
8INSERM-U955, Equipe 2, Laboratoire D'Excellence, GRex, Institut Mondor, Créteil, France
9Department of Internal Medicine, Reference Center of Sickle Cell Disease, Mondor University Hospital, Créteil, France
10Sickle cell referral center, Internal Medicine Unit, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Creteil, France
11INSERM-U955, EFS, Institut Mondor, Université Paris-Est Créteil, Team 2 Transfusion et maladies du globule rouge, Laboratoire d´Excellence GR-Ex, Créteil, France
12Etablissement Français du Sang, Creteil, France
13Service de Gynécologie Obstétrique,, Centre Hospitalier Intercommunal de Créteil, Creteil, France
14Department of Public Health and Biostatistics, Henri Mondor Hospital, Créteil, France
15service de gyneco-obstetrique, Centre Hospitalier Intercommunal de Créteil, Creteil, France
16UPEC, University Paris East Creteil, Creteil, France

*signifies non-member of ASH